{
  "id": 2639,
  "text": "438.Smith, H.O., et al.Is there a difference in survival for IA1 and IA2 adenocarcinoma of the uterine cervix?Gynecol Oncol 85, 229-241 (2002).439.Webb, J.C., Key, C.R., Qualls, C.R.& Smith, H.O.Population-based study of microinvasive adenocarcinoma of the uterine cervix.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 438.Smith, H.O., et al.Is there a difference in survival for IA1 and IA2 adenocarcinoma of the uterine cervix?Gynecol Oncol 85, 229-241 (2002).439.Webb, J.C., Key, C.R., Qualls, C.R.& Smith, H.O.Population-based study of microinvasive adenocarcinoma of the uterine cervix.\n\n<question>: ",
  "ChatGPT_response_0": "根据研究显示，IA1和IA2子宫颈腺癌患者之间的存活率可能存在一定差异。然而，对于哪种类型的存活率更高，还需要更多的研究和数据来作出准确的评估。在治疗选择和预后评估过程中，医生会综合考虑多种因素，包括肿瘤的分期、组织类型和个体患者的情况等。如果您或您认识的人受到此疾病影响，建议咨询专业医生以获取针对个体情况的指导和建议。",
  "query": "哪种子宫颈腺癌（IA1和IA2）的存活率更高？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 哪种子宫颈腺癌（IA1和IA2）的存活率更高？\n\n<reference text>: 438.Smith, H.O., et al.Is there a difference in survival for IA1 and IA2 adenocarcinoma of the uterine cervix?Gynecol Oncol 85, 229-241 (2002).439.Webb, J.C., Key, C.R., Qualls, C.R.& Smith, H.O.Population-based study of microinvasive adenocarcinoma of the uterine cervix.\n\n<reply>: ",
  "response": "根据研究显示，IA1和IA2子宫颈腺癌患者之间的存活率可能存在一定差异。然而，对于哪种类型的存活率更高，还需要更多的研究和数据来作出准确的评估。在治疗选择和预后评估过程中，医生会综合考虑多种因素，包括肿瘤的分期、组织类型和个体患者的情况等。如果您或您认识的人受到此疾病影响，建议咨询专业医生以获取针对个体情况的指导和建议。"
}